Drug name - Xyosted (autoinjector)

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9180259 ANTARES PHARMA INC Prefilled syringe jet injector Jan, 2026

(3 years from now)

US8562564 ANTARES PHARMA INC Prefilled syringe jet injector Jan, 2026

(3 years from now)

US9629959 ANTARES PHARMA INC Prefilled syringe jet injector Jan, 2026

(3 years from now)

US10478560 ANTARES PHARMA INC Prefilled syringe injector Jan, 2026

(3 years from now)

US9533102 ANTARES PHARMA INC Prefilled syringe jet injector Jan, 2026

(3 years from now)

US8021335 ANTARES PHARMA INC Prefilled syringe jet injector Oct, 2026

(4 years from now)

US10279131 ANTARES PHARMA INC Injection device with cammed RAM assembly Jul, 2031

(8 years from now)

US10905827 ANTARES PHARMA INC Injection device with cammed ram assembly Aug, 2031

(8 years from now)

US10357609 ANTARES PHARMA INC Needle assisted jet injection device having reduced trigger force Aug, 2031

(8 years from now)

US10821072 ANTARES PHARMA INC Needle assisted jet injection administration of testosterone compositions Jun, 2033

(10 years from now)

US10881798 ANTARES PHARMA INC Needle assisted injection device having reduced trigger force Feb, 2034

(11 years from now)

US11160751 ANTARES PHARMA INC Hematocrit modulation through needle assisted jet injection of testosterone Oct, 2034

(12 years from now)

US10238662 ANTARES PHARMA INC Needle assisted jet injection administration of testosterone compositions Feb, 2035

(12 years from now)

US10912782 ANTARES PHARMA INC Needle assisted injection administration of testosterone compositions Feb, 2035

(12 years from now)

US11191908 ANTARES PHARMA INC Syringe shock absorber for use in an injection device Oct, 2035

(13 years from now)

US9744302 ANTARES PHARMA INC Needle assisted jet injection device having reduced trigger force Nov, 2035

(13 years from now)

US9950125 ANTARES PHARMA INC Needle assisted jet injection administration of testosterone compositions Sep, 2036

(13 years from now)

US10646495 ANTARES PHARMA INC Testosterone ester triglyceride formulations Aug, 2038

(15 years from now)

Drugs and Companies using TESTOSTERONE ENANTHATE ingredient

Treatment: Method of administering testosterone enanthate subcutaneously

Dosage: SOLUTION;SUBCUTANEOUS

More Information on Dosage
Strength Dosage Availability
50MG/0.5ML (50MG/0.5ML) SOLUTION;SUBCUTANEOUS Prescription
75MG/0.5ML (75MG/0.5ML) SOLUTION;SUBCUTANEOUS Prescription
100MG/0.5ML (100MG/0.5ML) SOLUTION;SUBCUTANEOUS Prescription

availability in other generic markets.

Click on the highlighted region to filter.